SCHEMBL6579142

SCHEMBL6579142

CCC(NC(=O)OC(C)(C)C)C(Oc1cc(Cl)c(F)cc1C#N)c1ccoc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
NOS2 P35228 2/20 0.41
TRPA1 O75762 1/20 0.41
AAK1 Q2M2I8 5/20 0.36
NR3C1 P04150 1/20 0.33
CTSS P25774 3/20 0.33
CTSK P43235 3/20 0.33
BCL2A1 Q16548 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651383 0.81 NOS2 (0.50) CYP2D6SLC6A2SLC6A4NOS2TRPA1
SCHEMBL6531632 0.74 AAK1 (0.37) CYP2D6SLC6A2SLC6A4NOS2TRPA1
SCHEMBL6491446 0.69 NOS2 (0.72) CYP2D6SLC6A2SLC6A4NOS2BCL2A1
SCHEMBL6576720 0.69 CYP2D6 (0.40) CYP2D6SLC6A2SLC6A4NOS2AAK1
SCHEMBL6575167 0.69 SLC6A4 (0.53) CYP2D6SLC6A2SLC6A4NOS2
Fumaric Acid SCHEMBL6500083 0.69 NOS2 (0.67) CYP2D6SLC6A2SLC6A4NOS2BCL2A1
Fumaric Acid SCHEMBL6500086 0.69 NOS2 (0.67) CYP2D6SLC6A2SLC6A4NOS2BCL2A1
SCHEMBL6488974 0.68 NOS2 (0.64) CYP2D6SLC6A2SLC6A4NOS2TRPA1
Oxalic Acid SCHEMBL6500140 0.68 NOS2 (0.58) CYP2D6SLC6A2SLC6A4NOS2BCL2A1
Fumaric Acid SCHEMBL6576574 0.68 NOS2 (0.51) CYP2D6SLC6A2SLC6A4NOS2BCL2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6743939-B2 NITRIC OXIDE SYNTHASE INHIBITORS; SUCH AS 4-CHLORO-2-(((1)-4-(METHYLAMINO)-1-PHENYLBUTYL)OXY)BENZONITRILE ASTRAZENECA AB (SE) 2004-06-01 US disclosed
EP-1263714-B1 NOVEL PHENYLHETEROALKYLAMINE DERIVATIVES ASTRAZENECA AB (SE) 2004-04-28 EP disclosed
US-20030105161-A1 Novel phenylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105161-A1 Novel phenylheteroalkylamine derivatives NOS1, CYP1A1, NOS2 CYP2D6 65/4885SLC6A2 2667/4885SLC6A4 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.